In pharmaceutical development, even trace-level contaminants can impact patient safety, product stability, and regulatory approval. That’s why regulatory bodies worldwide enforce strict impurity controls—and why the ICH guidelines for impurities are considered the global benchmark for compliance. For a drug research firm, understanding impurity guidelines isn’t just a documentation requirement. It’s a strategic advantage that… Continue reading Understanding ICH Guidelines for Impurities


